WGS FY 2023 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

FY 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$203M-13.7% YoY

Gross Profit

$90M44.4% margin

Operating Income

-$181M-89.2% margin

Net Income

-$176M-86.8% margin

EPS (Diluted)

$-7.23

Cash Flow

Operating Cash Flow

-$180M

Free Cash Flow

-$186M

Stock-Based Comp.

-$326,000

Balance Sheet

Total Assets

$419M

Total Liabilities

$191M

Stockholders' Equity

$228M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$203M	$235M	-13.7%
Gross Profit	$90M	-$27M	+436.5%
Operating Income	-$181M	-$668M	+73.0%
Net Income	-$176M	-$549M	+68.0%